Dow Down0.32% Nasdaq Down0.62%

More On IMC.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Immuron Limited (IMC.AX)

-ASX
0.36 Down 0.03(7.69%) Apr 29, 1:43AM EDT
ProfileGet Profile for:
Immuron Limited
18 Kavanagh Street
Level 1
Southbank, VIC 3006
Australia - Map
Phone: 61 3 8648 4530
Fax: 61 3 9686 9460
Website: http://www.immuron.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

Business Summary 

Immuron Limited, a biopharmaceutical company, focuses on the research and development of polyclonal antibodies for the treatment and prevention of various diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. Its technology platform produces dairy colostrum- derived polyclonal antibodies used to treat a range of diseases, including infectious diseases, cancers, and chronic inflammatory diseases. The company markets Travelan, a product to prevent infection by enterotoxigenic escherichia coli, which is the cause of travelersÂ’ diarrhea. It is also developing IMM 124-E, a product in Phase II clinical trial for the treatment of non-alcoholic steatohepatitis/Type 2 diabetes; IMM 529 for the treatment of clostridium difficile infection; IMM-363 to treat of side effects caused by chemotherapy or radiation; and IMM-160 to reduce tumor size and suppress liver cancer. The company was founded in 1994 and is based in Southbank, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Immuron Limited

Key Executives 
 PayExercised
Mr. Peter Anastasiou ,
Exec. Vice Chairman
0.00N/A
Mr. Thomas Liquard , 44
Chief Exec. Officer
N/AN/A
Mr. Phillip Allen Hains BBus(Acc), MBA, CA, 57
Co-Chief Financial Officer and Company Sec.
N/AN/A
Mr. Peter Vaughan BBus(Acc), CA,
Co-Chief Financial Officer and Company Sec.
N/AN/A
Dr. Jerry Kanellos ,
Chief Operating and Scientific Officer
N/AN/A
Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.